Trial Profile
Impact of Statin Therapy on Adaptations to Aerobic Exercise
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2023
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- 06 Dec 2023 Planned End Date changed from 1 Jul 2023 to 30 May 2024.
- 06 Dec 2023 Planned primary completion date changed from 1 Jul 2023 to 30 May 2024.
- 06 Dec 2023 Status changed from recruiting to active, no longer recruiting.